Abnormal regulation of transforming growth factor-β receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II

Hypertension

Volumn 31, Issue 2, 1998, Pages 672-677

  Fukuda, Noboru ^a   Hu, Wen Yang ^a   Kubo, Atsushi ^a   Endoh, Morito ^a   Kishioka, Hirobumi ^a   Satoh, Chikara ^a   Soma, Masayoshi ^a   Izumi, Yoichi ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Rats, inbred SHR; Receptors; Transforming growth factors; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; ESSENTIAL HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031934184     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.672     Document Type: Article

References (35)

1. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle celk in spontaneously hypertensive rats. Hypertension. 1989;13:589-597.
2. Hamet P, Hadrava V, Kruppa U, Tremblay J. Vascular smooth muscle cell hyperresponsiveness to growth factors in hypertension. J Hypcrtcns. 1988; 5(suppl 4):S36-S39.
3. Hamet P, Hadrava V, Kruppa U, Tremblay J. Transforming growth factor-| expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1991;17:896-901.
4. Hahn AWH, Resink TJ, Bernhardt J, Ferracin F, Bühler FR. Stimulation of autocrine platelet-derived growth factor AA-homodimer and transforming growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;178:1451-1458.
5. Moses HL, Coffey RJ Jr, Leof EB, Lyon RM, Keski-Oja J. Transforming growth factor regulation of cell proliferation. J Cell Physiol. 1987;5:l-7.
6. Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell culture. J Cell Biol. 1987;105: 465-471.
7. Goodman LV, Majack RA. Vascular smooth muscle cells express distinct transforming growth factor- receptor phenotypes as a function of cell density in culture. J Biol Chem. 1989;264:5241-5244.
8. Massague J, Like B. Cellular receptors for type transforming growth factor: ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem. 1985;260:2636-2645.
9. Cheifets S, Weatherbee JA, Tsang ML, AndersonJK, Mole JE, Lucas R, Massague J. The transforming growth factor- system, a complex pattern of cross-reactive ligands and receptors. Cell. 1987;48:409-415.
10. Wang X, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGF- type III receptor. Cell. 1991;67:797-805.
11. Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J, Wrana JL. Identification of human activin and TGF type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 1993;75: 671-680.
12. Franzen P, Dijeke P, Ichijo H, Yamashita H, Schultz P, Helden C, Miyazono K. Cloning of a TGF type I receptor that forms a heteromeric complex with the TGF type II receptor. Cell. 1993;75:681-692.
13. Agrotis A, Saltis J, Bobik A. Transforming growth factor-l gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 1994:23:593-599.
14. Fukuda N, Kubo A, Izumi Y, Sonia M, Kanmatsuse K. Characteristics and expression of transforming growth factor-/3 receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 1995;13:831-837.
15. Takeuchi K, Nakamura N, Cook NS, Pratt RE, Dzau VJ. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun. 1990;172: 1189-1194.
16. Schelling P, Fisher H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens. 1991;9:3-5.
17. StoufTer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on automne production of transforming growth factor-/3. Circ Res. 1992; 70:820-828.
18. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor \expression determines growth response to angiotensin II. J Clin Invest. 1992;90: 456-461.
19. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
20. Bunkenburg B, Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1992;20:746-754.
21. Paquet JI, Bandonim-Legros M, Brunelle G, Meyr P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive nK.J Hypertens. 1990;8:565-572.
22. Koibuchi Y, Lee \VS, Gibbons GH, Pratt RE. Role of transforming growth factor- l in the cellular growth response to angiotensin II. Hypertension. 1993;21:1046-1050.
23. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
24. Ross R. The smooth muscle cell, II: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;50:172-186.
25. Majack RA, Cook SC, Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol. 1985;101: 1059-1070.
26. Scatchard G. The attractions of proteins for small molecules and ions. Ann N YAcad Sei. 1949;51:660-672.
27. Mocharla H, Mocharla R, Hocks ME. Coupled reverse transcriptionpolymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping. Gene. 1990;93:271-275.
28. Chan YL, Lin A, McNallyJ, Pelleg D, Meyuhas O, Wool I. The primary structure of rat ribosomal protein L19. J Biol Chcm. 1987;262:1111-1115.
29. Battegay EJ, Raines EW, Seifen RA, Bowen-Pope DF, ROSS R. TGF- induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
30. Massague J. TGF signaling: receptors, transducers, and Mad proteins. Cell. 1996;85:947-950.
31. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-0 receptor. Nature. 1994;370:341-347.
32. Kubo A, Fukuda N, Soma M, Izumi Y, Kanmatsuse K. Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats. J Caraiovasc Pliarmacol. 1996:27:58-63.
33. Fukuda N, Satoh C, Soma M, Hu W-Y, Kishioka H, Watanabe Y, Izumi Y, Kanmatsuse K. Angiotensin II-producing system in vascular smooth muscle cells from spontaneously hypertensive nts.Jpn Circ]. 1997;61:40. Abstract.
34. Dzau VJ, Brody T, Ellison KE, Pratt RE, Ingelfinger JR. Tissue-specific regulation of renin expression in the mouse. Hypertension. 1987;9(suppl III):III-36-III-41.
35. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin-stimulated protein synthesis in cultured smooth muscle cells. Hypertension. 1989;13: 305-314.